Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Lupin Ltd. is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a wide range of branded and generic formulations, as well as active pharmaceutical ingredients (APIs). The company focuses on the cardiovascular, anti-asthma, anti-diabetic, CNS, and anti-infective segments, significantly impacting these vital healthcare sectors. Lupin's operations span across multiple regions including North America, Europe, Asia-Pacific, and emerging markets, emphasizing its commitment to enhancing global healthcare access. Notably, Lupin invests heavily in research and development to drive product innovation and maintains robust manufacturing capabilities to ensure quality and compliance. As one of the leading pharmaceutical firms in India, Lupin Ltd. plays a crucial role in the global generic drug market, contributing to the availability of cost-effective medications and expanding its therapeutic reach. Its strategic focus on fostering partnerships and enhancing its specialty portfolio underscores its market significance in advancing healthcare solutions worldwide.